Affiliation:
1. Department of Transfusion Medicine, Medanta – The Medicity , Gurgaon , India
Abstract
Abstract
Anti-f is produced by exposure to the compound antigen ce (f) on red blood cells (RBCs), expressed when both c and e are present on the same protein (cis position). Although anti-f was discovered in 1953, there are few cases reported worldwide because the presence of anti-f is often masked by anti-c or anti-e and is not generally found as a single antibody. In the present case, anti-f was identified by using three-cell screening and 11-cell identification panels. The identification of anti-f was further supported by additional testing, including (1) Rh antigen typing; (2) antibody identification panels (enzyme-treated panel [ficin] and an in-house–constructed Rh panel); (3) look-back and phenotyping of donor RBC units, which were responsible for alloimmunization; and (4) molecular testing of the patient’s RBCs.
Reference7 articles.
1. Harmening DM. The RH blood group system. In: Modern blood banking and transfusion practices. 7th ed. Philadelphia, PA: F.A. Davis Company; 2019:165.
2. Chow PK, Tsoi WC. Antibody against compound antigen ce (f). J Hong Kong Inst Med Lab Sci 1997;98:19–21.
3. Jator EK, Pedde E. Anti-f in a 24-year-old male: a case study. Clin Lab Sci 2010;23:68–71.
4. Nakamura Y, Ohsawa T, Furuta Y, Tokida M, Ichikawa K. Successful identification of anti-F alloantibody in a non-transfused male patient employing ID-micro typing system gel cards. J Blood Disord Transfus 2015;6:2.
5. Nah H, Shin S, Kim S, Lee E, Kim HO. A case report of anti-f (ce) identified in a patient with pancreatic cancer. Korean J Blood Transfus 2016;27:174–82.